You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anastrozole

Showing 26 - 50 of 451
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Baltimore (Anastrozole, Letrozole)

Recruiting
  • Breast Cancer
  • Baltimore, Maryland
    University of Maryland Greenebaum Cancer Center
Apr 29, 2022

Advanced Breast Cancer Trial in Shanghai (SHR6390 Tablets, Placebo Tablets, Letrozole or Anastrozole Tablets)

Active, not recruiting
  • Advanced Breast Cancer
  • SHR6390 Tablets
  • +2 more
  • Shanghai, China
    Nayima Bayaxi
May 31, 2021

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Mar 7, 2023

Breast Cancer, Breast Tumors Trial in United States (Bevacizumab, Anastrozole, Fulvestrant)

Completed
Has Results
  • Breast Cancer
  • Breast Neoplasms
  • Fort Myers, Florida
  • +10 more
Nov 16, 2021

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)

Not yet recruiting
  • ER-positive Breast Cancer
  • +3 more
  • (no location specified)
Aug 22, 2022

Breast Cancer Trial in Shanghai (OFS + Anastrozole, OFS + Exemestane)

Completed
  • Breast Cancer
  • OFS + Anastrozole
  • OFS + Exemestane
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)

Completed
Has Results
  • Breast Cancer
  • Cancer
  • Nivolumab
  • +2 more
  • Whittier, California
  • +35 more
Jul 14, 2022

HER2 Low Advanced or Metastatic Breast Cancer Trial (SHR-A1811 & Dalpiciclib Isethionate Tablets, SHR-A1811 & Fulvestrant,

Not yet recruiting
  • HER2 Low Advanced or Metastatic Breast Cancer
  • SHR-A1811 & Dalpiciclib Isethionate Tablets
  • +2 more
  • (no location specified)
Mar 19, 2023

DCIS Trial in Orange (Anastrozole)

Completed
Has Results
  • DCIS
  • Anastrozole
  • Orange, California
    Chao Family Comprehensive Cancer Center
Apr 19, 2021

Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)

Active, not recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
    State Key Laboratory of Oncology in South China, Sun Yat-sen Uni
Jan 27, 2023

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

Breast Cancer Trial in France (anastrozole, fulvestrant)

Completed
  • Breast Cancer
  • Clermont-Ferrand, France
  • +5 more
Jun 4, 2021

Early-stage Breast Cancer Trial in Ottawa (Endocrine Therapy and Radiotherapy)

Completed
  • Early-stage Breast Cancer
  • Endocrine Therapy and Radiotherapy
  • Ottawa, Ontario, Canada
    Ottawa Hospital Research Institute
Sep 28, 2022

Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

Not yet recruiting
  • Breast Cancer
  • Cancer of the Breast
  • VENTANA MIB-1 Ki67 assay
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 18, 2023

Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)

Active, not recruiting
  • Breast Neoplasms
  • Perjeta Injectable Product
  • +13 more
  • Mönchengladbach, Germany
    Evangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Jul 11, 2023

Breast Cancer Trial in Guangzhou (Tucidinostat, Capecitabine, Endocrine Therapy)

Recruiting
  • Breast Cancer
  • Guangzhou, Gangdong, China
    Shusen Wang
Nov 1, 2022

Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +9 more
  • anastrozole
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 9, 2022

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Trial in Algeria, Jordan, Saudi Arabia (Combination of

Not yet recruiting
  • Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
  • Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
  • Blida, Algeria
  • +6 more
Dec 28, 2021

Breast Cancer Trial in Lexington, East Syracuse (TOL2506, Tamoxifen, Letrozole tablets)

Enrolling by invitation
  • Breast Cancer
  • Lexington, Kentucky
  • +1 more
Jan 9, 2023

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Advanced Breast Cancer Trial in China (SHR6390, Letrozole or anastrozole or Fulvestrant)

Active, not recruiting
  • Advanced Breast Cancer
  • SHR6390
  • Letrozole or anastrozole or Fulvestrant
  • Ha'erbin, Heilongjiang, China
  • +3 more
May 31, 2021

Hypogonadism, Hypogonadotropic, Obesity Trial in Houston (anastrozole (1 mg/day), Placebo)

Recruiting
  • Hypogonadism, Hypogonadotropic
  • Obesity
  • anastrozole (1 mg/day)
  • Placebo
  • Houston, Texas
    Michael E. DeBakey VAMC
Jan 19, 2022

Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer Trial (Ribociclib, Fulvestrant,

Not yet recruiting
  • Locoregional Recurrence
  • +2 more
  • (no location specified)
Jul 18, 2022